**INSTITUTION
Discharge Summary
Name :
**NAME[AAA , BBB]
Acct # :
**ID-NUM
MRN :
**ID-NUM
Admitted :
**DATE[Jan 23 2008]
Discharged :
**DATE[Jan 27 2008]
Dict :
**NAME[WWW , VVV]
Attend :
**NAME[ZZZ , YYY]
CONSULTATIONS MADE :
1. **NAME[UUU TTT] , MD , hematology / oncology .
2. **NAME[SSS M RRR] , MD , family practice .
PROCEDURES DONE :
She had a blood transfusion performed .
PRINCIPAL DIAGNOSIS :
Polycythemia vera converting to myelodysplastic syndrome .
SECONDARY DIAGNOSIS :
None .
HISTORY :
Ms. **NAME[AAA] is a **AGE[in 60s]- year - old female known to Dr. **NAME[ZZZ] for the treatment of her polycythemia vera that converted to myelodysplastic syndrome .
She has had the disease for greater than 10 years and was treated with Hydrea .
Two to three years ago , she developed decreasing counts , specifically her hemoglobin and hematocrit , and then was treated with Wydase but was not able to tolerate this .
She was then just maintained on Hydrea and Procrit with p.r.n. blood transfusions in **DATE[Oct 2007] .
At this time , she presented to the office with a hemoglobin of 7 and has required frequent blood transfusions since .
With the blood transfusions , she gets increasing splenomegaly which is uncomfortable and decreases her appetite .
The patient reports that her last transfusion was 2 weeks ago .
Her hemoglobin is 7.6 , and she received 2 units .
When she presented to the office yesterday for her weekly Procrit , her hemoglobin was found to be decreased at 7.1 , and the splenomegaly again increased .
On physical exam , her vital signs were within normal limits , and her physical exam was unremarkable except for her splenomegaly .
Laboratories were as above .
She was then admitted to the hospital for further management of her anemia and splenomegaly .
**INSTITUTION COURSE :
Ms. **NAME[AAA] was admitted to the hospital for further management of her anemia and splenomegaly .
For her anemia , she was given a blood transfusion .
This had to be delayed secondary to her many antibodies and difficulties finding a match .
It was able to be given , and she tolerated it well .
Dr. **NAME[TTT] of hematology was also consulted for his second opinion regarding what to do for her multitude of hematologic problems .
He recommended that the Hydrea be decreased , and in case that her disease continues to progress , to consider treating her with thalidomide and prednisone .
With this treatment plan , Ms. **NAME[AAA] 's counts improved , and she was able to be discharged .
DISPOSITION :
Ms. **NAME[AAA] is being discharged to home .
Activities as tolerated .
Diet is unrestricted .
She is being discharged on Fosamax 70 mg weekly , Colace 100 mg twice a day , Hydrea 500 mg daily , multivitamin , Protonix 40 mg daily , and vitamin E .
She is to follow up with Dr. **NAME[ZZZ] in 2 to 3 days at the office .
______________________________
**NAME[VVV WWW] , PA
HS Job # 470806 / 36756 / 31922
SHY # **ID-NUM
D :
**DATE[Feb 13 2008] 15:51
T :
**DATE[Feb 14 2008] 02:56
**CARBON-COPY
